v3.26.3
Consolidated Condensed Statements of Cash Flow - USD ($)
$ in Millions
9 Months Ended
Oct. 03, 2026
Sep. 27, 2025
OPERATING ACTIVITIES    
Net earnings $ 122.4 $ 68.5
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 15.8 20.3
Deferred income taxes 0.3 0.2
Stock-based compensation expense 21.1 18.4
Pension Expense (Reversal of Expense), Noncash 0.0 (0.5)
Environmental and other related costs, net of cash payments (5.8) (8.3)
Other Noncash Income (Expense) (7.2) (7.4)
Changes in operating assets and liabilities:    
Increase (Decrease) in Accounts Receivable (57.0) 5.3
Increase (Decrease) in Inventories (4.9) (41.9)
Increase (Decrease) in Other Operating Assets 24.5 (4.9)
Accounts payable (12.7) (55.2)
Other operating liabilities (22.9) (0.7)
Net cash provided by (used in) operating activities 73.6 (6.2)
INVESTING ACTIVITIES    
Payments to Acquire Property, Plant, and Equipment (7.7) (13.9)
Proceeds from Life Insurance Policy 0.2 2.2
Payment for (Proceeds from) Other Investing Activity (0.3) (1.2)
Net cash used in investing activities (7.8) (12.9)
FINANCING ACTIVITIES    
Repayments of Lines of Credit (398.0) (355.0)
Proceeds from Lines of Credit 323.0 415.0
Cash Paid on Borrowings From Company Owned Life Insurance Policies (12.4) 0.0
Repayments of Long-Term Debt 0.0 (32.5)
Payments of Debt Issuance Costs 0.0 (3.9)
Payments of Ordinary Dividends, Common Stock (25.3) (25.0)
Payment, Tax Withholding, Share-based Payment Arrangement (8.7) (9.1)
Proceeds from the exercise of stock options 0.2 12.2
Net cash provided by (used in) financing activities (121.2) 1.7
Effect of foreign exchange rate changes (2.8) (0.8)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (58.2) (18.2)
Cash and cash equivalents at beginning of the year 206.3 152.1
Cash and cash equivalents at end of the quarter $ 148.1 $ 133.9